Global Mangiferin Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Liquid, Capsule, and Powder), By Application (Nutraceuticals, Food and Beverages, Cosmetics, and Pharmaceuticals), By Distribution Channel (Specialty Stores, Online Stores, Supermarkets, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Mangiferin Market Insights Forecasts to 2035

• The Global Mangiferin Market Size Was Estimated at USD 244.94 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.41% from 2025 to 2035
• The Worldwide Mangiferin Market Size is Expected to reach USD 485.11 Million By 2035
• North America is Expected to Grow the fastest during the forecast period.

The global mangiferin market size was worth around USD 244.94 million in 2024 and is predicted to grow to around USD 485.11 million by 2035 with a compound annual growth rate (CAGR) of 6.41% from 2025 and 2035. The market expansion is facilitated by increasing cultivation of the mangoes in farming sectors, availability of a wide range of mangiferin supplements in the market, which possess therapeutic potential effects, and extensive usage in cosmetics and pharmaceuticals.

Market Overview

The global mangiferin market involves the extraction and commercialization of mangiferin, a phytochemical constituent extracted from the mango fruit that possesses anti-inflammatory, anti-oxidant, and beneficial therapeutic properties. Mangiferin is a naturally occurring polyphenol that is a member of the xanthone class and can be found in herbs such as honey bush and Iris unguicularis. In an attempt to stop inflammation and cardiac apoptosis, it can suppress the expression of proinflammatory and pro-apoptotic genes and has iron-chelating and antioxidant qualities. By controlling intracellular calcium homeostasis, it also safeguards the heart. Since it suppresses collagen type IV, TGFβ-1, and ECM in diabetic nephropathy in Wistar rats, mangiferin's pharmacological role in diabetes and its related complications is well known.

Several government initiatives drive the market growth. For instance, various government initiatives investing in the cultivation of mango fruits result in the wide-scale extraction of the crude substance called mangiferin. The Indian state government has launched the Mango Development Scheme, which offers a 50% subsidy of Rs 60,000 per hectare to encourage farmers to grow mangoes. The program also includes a micro-irrigation program that offers small and marginal farmers 80% support for community borewells and 80% support for drip, mini, and micro sprinklers. The Agricultural and Processed Food Products Export Development Authority (APEDA) helps Bihar export about 1200 MT of fresh mangoes to the UK, the Middle East, and New Zealand. Bihar is home to distinctive mango flavors like Dudhia Malda, Jardalu, and Amrapali.

Globally, the growing incidence of chronic diseases fuels the growth of the market. For example, the increasing prevalence of diabetes escalates the demand for anti-diabetic treatments, such as herbal supplements, including mangiferin-based supplements, leading to the market expansion. Diabetes is a global health issue affecting millions of people, affecting all demographics. It's a chronic condition causing high blood glucose levels due to inadequate insulin production. The data provided by the International Diabetes Federation states that in 2021, 537 million people were affected, accounting for 10.5% of the global population. The disease costs $966 billion in healthcare, with projections suggesting a rise to 783 million by 2045.

Report Coverage

This research report categorizes the mangiferin market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the mangiferin market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the mangiferin market.

Driving Factors

Expansion of the food and beverages industry:

Companies of mangiferin have a significant opportunity due to the growing trend of functional foods and beverages. These products promote overall health as they contain bioactive compounds such as vitamins, polyphenols, and antioxidants. Mangiferin, a naturally occurring polyphenol in mango leaves, is recognized for its immune-stimulating, anti-inflammatory, and antioxidant properties. As consumers become more aware of lifestyle-related diseases like diabetes, obesity, and cardiovascular disorders, they are increasingly turning to preventive nutrition. Mangiferin serves as an excellent complement to these products due to its ability to regulate blood sugar levels, improve metabolic performance, and support heart health. The beverage industry has a range of promising products, including herbal teas, energy drinks, sports nutrition products, functional snacks, yogurts, and fortified foods. The incorporation of mangiferin into these offerings is expected to drive market growth as research substantiates its health benefits.

Extensive usage of mangiferin in the cosmetics industry:

A polyphenol found in mango leaves and bark, mangiferin is becoming increasingly popular in the cosmetics sector due to its anti-inflammatory, antioxidant, and skin-rejuvenating properties. It combats oxidative stress, halts inflammatory processes, and promotes collagen production and hydrated skin. As consumer preferences shift toward natural formulations and clean beauty, mangiferin's organic origin and scientific support have contributed to its growing presence in skincare products. Awareness of skin health issues is expected to drive increased use of mangiferin, leading to an expansion of the mangiferin market.

Restraining Factors

The mangiferin market faces obstacles such as complexity in the extraction of mangiferin from the mango, higher cost of the extraction procedure, and fluctuations in the cost of the raw materials, which limit the growth of the market.

Market Segmentation

The mangiferin market share is classified into product type, application, and distribution channel.

• The powder segment accounted for a significant share in 2024 and is projected to grow at a remarkable CAGR during the forecast period.

Based on the product type, the mangiferin market is divided into liquid, capsule, and powder. Among these, the powder segment accounted for a significant share in 2024 and is projected to grow at a remarkable CAGR during the forecast period. The segmental expansion is attributed to the greater physical and chemical stability, longer shelf life, extensive usage of the mangiferin powder in nutraceutical and pharmaceutical industries, cost-effectiveness, and ease of administration.

• The nutraceutical segment held a substantial share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the application, the mangiferin market is divided into nutraceuticals, food and beverages, cosmetics, and pharmaceuticals. Among these, the nutraceutical segment held a substantial share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The sector's growth is ascribed to the increasing prevalence of diabetes, cancer, and cholesterolemic, rising awareness of the nutraceuticals and herbal supplements, cost-effectiveness of the allopathic medications, and growing usage of mangiferin as an antioxidant supplement.

• The online stores segment accounted for a significant share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the distribution channel, the mangiferin market is divided into specialty stores, online stores, supermarkets, and others. Among these, the online stores segment accounted for a significant share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The sectoral dominance is accelerated by consumer convenience, 24-hour accessibility, facilitated with return and exchange provisions, flexibility, availability of a wide range of products, and personalized experience.

Regional Segment Analysis of the Mangiferin Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Asia Pacific is anticipated to hold the largest share of the mangiferin market over the predicted timeframe.

Asia Pacific is anticipated to hold the largest share of the mangiferin market over the predicted timeframe. This is attributed to the rising cultivation and production of mangoes and extensive usage of the natural and herbal ingredients such as mangiferin. India, China, and Thailand are considered leading regions in the mangiferin market in the Asia Pacific region. The rising proportion of the geriatric population and increasing cases of diseases associated with oxidative stress and inflammatory conditions escalate the demand for medicinal supplements, which leads to the growth of the market in this region.                                                                                                                             

North America is expected to grow at a rapid CAGR in the mangiferin market during the forecast period.  Increased demand for natural ingredients, growing health consciousness, the growth of functional foods and dietary supplements, improvements in extraction and formulation, and an increase in e-commerce and direct-to-consumer sales are all driving the growth of the mangiferin market in North America. Canada and the United States are placed at a significant position in this region. Companies are creating high-purity extracts and nano-delivery systems to improve bioavailability as consumers turn to plant-based bioactive compounds. Products based on mangiferin are becoming more widely available throughout the region, owing to online platforms.

Europe is projected to hold a significant share of the mangiferin market throughout the estimated period. Government programs, research funding, growing pharmaceutical applications, sustainability, ethical sourcing, customized nutrition, and growing partnerships and collaborations all have an impact on the European mangiferin market. Innovation is being propelled by mangiferin's neuroprotective, antiviral, and antioxidant qualities. Its potential in antiviral formulations, nerve protection, and antitumor treatments is being investigated. Businesses are concentrating on environmentally friendly extraction techniques to comply with European environmental standards. The market is being driven by the rising demand, especially in Germany, France, and the UK, for natural cosmetics and health supplements.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the mangiferin market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Enzo Life Sciences, Inc.
• BioVision Inc.
• Carbosynth Limited
• ChromaDex Inc.
• Abcam plc
• Indena S.p. A.
• Thermo Fisher Scientific Inc.
• LKT Laboratories, Inc.
• Selleck Chemicals
• Sigma-Aldrich Corporation
• Cayman Chemical Company
• Toronto Research Chemicals
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In September 2024, the in vitro study of mangiferin on rats states that mangiferin ameliorates polycystic ovary syndrome (PCOS) by improving hormonal imbalances, insulin resistance, gut microbiota dysbiosis, and ovarian cell apoptosis. This research study was published in the Journal, Frontiers in Pharmacology.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the mangiferin market based on the below-mentioned segments:

Global Mangiferin Market, By Product Type

• Liquid
• Capsule
• Powder

Global Mangiferin Market, By Application

• Nutraceuticals
• Food and Beverages
• Cosmetics
• Pharmaceuticals

Global Mangiferin Market, By Distribution Channel

• Specialty Stores
• Online Stores
• Supermarkets
• Others

Global Mangiferin Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa